Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jan 26;21(3):804. doi: 10.3390/ijms21030804

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

(a) Median fluorescence intensity ratios (MFIR) of CD11b, CD54, CD68, CD80 and CD86 staining in BV-2 cells without treatment (control) and treated for 24 h with 1 or 5 mM glycine (Gly1, Gly5) or for 24 h with LPS/IFN-γ in the absence and presence of 1 or 5 mM glycine (Gly1, Gly5), respectively. Asterisks indicate significances compared to control (* p < 0.05; ** p < 0.01); the hash indicates significance compared to LSP/IFN-γ treatment (# p < 0.05). Six independent experiments were performed per treatment. (b) Reduced glutathione/oxidized glutathione (GSH/GSSG) ratios measured under the same conditions as in (a). Three independent experiments were performed per treatment.